BioSpace News Archive

Apellis Pharmaceuticals, Inc. today announced that the company approved the grant of equity awards to 13 new employees with a grant date of May 1, 2023.

Chinook Therapeutics, Inc. today announced that the Compensation Committee of the Company’s Board of Directors approved new employment inducement grants of stock options to purchase a total of 88,000 shares of common stock and restricted stock units for 44,600 shares with a grant date of April 28, 2023.

Entera Bio Ltd. today reported corporate updates and financial results for the first quarter ended March 31, 2023.

Chinook Therapeutics, Inc. today announced upcoming data presentations at the 60th ERA Congress from June 15 – 18, 2023, both virtual and live in Milan, Italy.

Pardes Biosciences, Inc. (NASDAQ: PRDS) today reported financial results for the first quarter ended March 31, 2023.

Arcutis Biotherapeutics, Inc. today reported the grant of an aggregate of 84,000 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 15,000 shares of Arcutis’ common stock to nine newly hired employees.

Ultragenyx Pharmaceutical Inc. today announced that Emil D. Kakkis, M.D., Ph.D., the company’s chief executive officer and president, will present at Bank of America’s 2023 Health Care Conference on Wednesday, May 10, 2023, at 9:20 a.m. PT.

Mirati Therapeutics, Inc. today announced that the company granted equity awards to 2 new employees with a grant date of May 1, 2023, as equity inducement awards outside of the company’s 2022 Equity Incentive Plan (but under the terms of the company’s Inducement Plan) and material to the employees’ acceptance of employment with the company.

Atara Biotherapeutics, Inc. today reported the grant of 6,250 restricted stock units of Atara’s common stock to one newly hired employee.

Savara Inc. today announced the grant of inducement awards to two new employees.